L60 MD003733/MD/NIMHD NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2012	3
2018	1
2019	1
2020	1
2021	2
2022	2
2023	3
2024	1

1

Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation.

Bueno MJ, Mouron S, Caleiras E, Martínez M, Manso L, Colomer R, Quintela-Fandino M. Bueno MJ, et al. Clin Transl Oncol. 2024 May;26(5):1273-1279. doi: 10.1007/s12094-023-03329-9. Epub 2023 Oct 18. Clin Transl Oncol. 2024. PMID: 37851244 Free PMC article.

2

The Novel Synthetic Antibiotic BDTL049 Based on a Dendritic System Induces Lipid Domain Formation while Escaping the Cell Envelope Stress Resistance Determinants.

Popp PF, Lozano-Cruz T, Dürr F, Londaitsbehere A, Hartig J, de la Mata FJ, Gómez R, Mascher T, Revilla-Guarinos A. Popp PF, et al. Pharmaceutics. 2023 Jan 16;15(1):297. doi: 10.3390/pharmaceutics15010297. Pharmaceutics. 2023. PMID: 36678925 Free PMC article.

3

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.

Jimeno R, Mouron S, Salgado R, Loi S, Pérez-Mies B, Sánchez-Bayona R, Manso L, Martínez M, Garrido-García A, Serrano-Pardo R, Colomer R, Quintela-Fandino M. Jimeno R, et al. Clin Transl Oncol. 2023 Apr;25(4):1124-1131. doi: 10.1007/s12094-022-03006-3. Epub 2022 Dec 12. Clin Transl Oncol. 2023. PMID: 36508123 Free PMC article.

4

Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.

Ferrer-Lorente R, Lozano-Cruz T, Fernández-Carasa I, Miłowska K, de la Mata FJ, Bryszewska M, Consiglio A, Ortega P, Gómez R, Raya A. Ferrer-Lorente R, et al. Biomacromolecules. 2021 Nov 8;22(11):4582-4591. doi: 10.1021/acs.biomac.1c00884. Epub 2021 Oct 6. Biomacromolecules. 2021. PMID: 34613701 Free PMC article.

5

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells.

Hühn D, Martí-Rodrigo P, Mouron S, Hansel C, Tschapalda K, Porebski B, Häggblad M, Lidemalm L, Quintela-Fandino M, Carreras-Puigvert J, Fernandez-Capetillo O. Hühn D, et al. Mol Oncol. 2022 Jan;16(1):148-165. doi: 10.1002/1878-0261.13083. Epub 2021 Aug 29. Mol Oncol. 2022. PMID: 34392603 Free PMC article.

6

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.

Quintela-Fandino M, Holgado E, Manso L, Morales S, Bermejo B, Colomer R, Apala JV, Blanco R, Muñoz M, Caleiras E, Iranzo V, Martinez M, Dominguez O, Hornedo J, Gonzalez-Cortijo L, Cortes J, Gasol Cudos A, Malon D, Lopez-Alonso A, Moreno-Ortíz MC, Mouron S, Mañes S. Quintela-Fandino M, et al. Breast Cancer Res. 2020 Nov 11;22(1):124. doi: 10.1186/s13058-020-01362-y. Breast Cancer Res. 2020. PMID: 33176887 Free PMC article. Clinical Trial.

7

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition.

Quintela-Fandino M, Apala JV, Malon D, Mouron S, Hornedo J, Gonzalez-Cortijo L, Colomer R, Guerra J. Quintela-Fandino M, et al. Breast Cancer Res. 2019 May 24;21(1):69. doi: 10.1186/s13058-019-1152-x. Breast Cancer Res. 2019. PMID: 31126332 Free PMC article. Clinical Trial.

8

p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1.

Quiñones M, Al-Massadi O, Folgueira C, Bremser S, Gallego R, Torres-Leal L, Haddad-Tóvolli R, García-Caceres C, Hernandez-Bautista R, Lam BYH, Beiroa D, Sanchez-Rebordelo E, Senra A, Malagon JA, Valerio P, Fondevila MF, Fernø J, Malagon MM, Contreras R, Pfluger P, Brüning JC, Yeo G, Tschöp M, Diéguez C, López M, Claret M, Kloppenburg P, Sabio G, Nogueiras R. Quiñones M, et al. Nat Commun. 2018 Aug 24;9(1):3432. doi: 10.1038/s41467-018-05711-6. Nat Commun. 2018. PMID: 30143607 Free PMC article.

9

Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.

Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. Terrell DR, et al. Am J Hematol. 2012 Sep;87(9):843-7. doi: 10.1002/ajh.23226. Epub 2012 Jun 20. Am J Hematol. 2012. PMID: 22718340 Free PMC article.

10

Prevalence of primary immune thrombocytopenia in Oklahoma.

Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Terrell DR, et al. Am J Hematol. 2012 Sep;87(9):848-52. doi: 10.1002/ajh.23262. Epub 2012 Jun 5. Am J Hematol. 2012. PMID: 22674643 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year